Management of Acute Myeloid Leukemia in 2020: A Paradigm Shift for Older Adults? SPOC

Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.

Learning Objectives

  • Discuss pathogenesis/etiology of AML
  • Explain diagnostic testing in AML
  • Describe management of AML in older patient populations in the context of recent drug approvals
Course summary
Available credit: 
  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Course opens: 
07/01/2020
Course expires: 
12/31/2027
Rating: 
0
Photo of Joshua Zeidner, MD 

Joshua Zeidner, MD

Assistant Professor
Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Joshua Zeidner, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.

 

This Non-Credit Course does NOT have accreditation for continuing education credits.

The course offers only general participation certificates.

Available Credit

  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Please login or register to take this course.